Publications Database

Rizzo R. , Pavone P. (2016)

Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders.

Expert Review of Neurotherapeutics

August, 16(8), pp. 867-874.

Read Abstract (New Window)

Robb A. S. (2010)

Managing irritability and aggression in autism spectrum disorders in children and adolescents.

Developmental Disabilities Research Reviews

16(3), pp. 258-264

Read Abstract (New Window)

Robb A. S. et al. (2011)

Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.

Primary Care Companion to CNS Disorders

13(1), pii: PCC.10m01008

Read Abstract (New Window) Read Full (New Window)

Roke Y. et al. (2012)

Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment.

European Journal of Endocrinology

167(6), pp. 855-863.

Read Abstract (New Window)

Roke Y. et al. (2012)

Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.

Journal of Child and Adolescent Psychopharmacology

22(6), pp. 432-439.

Read Abstract (New Window)

Rosenberg R. E. et al. (2010)

Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

Journal of Autism and Developmental Disorders

40(3), pp. 342-351.

Read Abstract (New Window)

Roser P. et al. (2009)

Paliperidone in an adult patient with Asperger syndrome: Case report.

Pharmacopsychiatry

42(2), pp. 78-79

Rothenberger A. (1993)

Psychopharmacological treatment of self-injurious behavior in individuals with autism.

Acta Paedopsychiatrica

56(2), pp. 99-104

Read Abstract (New Window)

Rugino T. A. , Janvier Y. (2005)

Aripiprazole in children and adolescents: clinical experience.

July, 20(7), pp. 603-610.

Read Abstract (New Window)

Samuel R. , Attard A. , Kyriakopoulos M. (2013)

Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study.

BMC Psychiatry

13(1), pp. 244

Read Abstract (New Window) Read Full (New Window)

Sanchez L. e. et al. (1995)

A comparison of live and videotape ratings: clomipramine and haloperidol in autism.

Psychopharmacology Bulletin

31(2), pp. 371-378.

Read Abstract (New Window)

Santosh P. J. , Baird G. (2001)

Pharmacotherapy of target symptoms in autistic spectrum disorders.

Indian Pediatrics

68(5), pp. 427-431

Read Abstract (New Window)

Scahill L. et al. (2012)

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Journal of the American Academy of Child and Adolescent Psychiatry

51(2), pp. 136-146

Read Abstract (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

11(4), pp. 377-388

Read Abstract (New Window)

Scahill L. , Koenig K. (1999)

Pharmacotherapy in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychiatric Nursing

12(1), pp. 41-43

Read Abstract (New Window)

Scahill L. et al. (2016)

Weight gain and metabolic consequences of risperidone in young children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

May, 55(5), pp. 415-423.

Read Abstract (New Window)

Schreier H. (1998)

Risperidone for young children with mood disorders and aggressive behavior.

Journal of Child and Adolescent Psychopharmacology

8(1), pp. 49-59

Read Abstract (New Window)

Scott L. , Dhillon S. (2007)

Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents.

Pediatric Drugs

9(5), pp. 343-354

Read Abstract (New Window)

Scott L. , Dhillon S. (2008)

Spotlight on risperidone in irritability associated with autistic disorder in children and adolescents.

CNS Drugs

22(3), pp. 259-262

Read Abstract (New Window)

Self T. L. , Hale L. S. , Crumrine D. (2010)

Pharmacotherapy and children with autism spectrum disorder: A tutorial for speech-language pathologists.

Language, Speech, and Hearing Services in Schools

41 pp. 367-375.

Read Abstract (New Window)